S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
pixel
Log in
OTCMKTSMKTS:AVXT

AVAX Technologies Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume616,888 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-4.1
AVAX Technologies, Inc., a development stage biopharmaceutical company, develops autologous cell vaccine technologies for the treatment of cancer. The company's product candidates that have completed phase II clinical trials include M-VAX for the treatment of melanoma and O-VAX for the treatment for ovarian cancer. It also develops LungVax for the treatment of non-small cell lung cancer. The company was formerly known as Walden Laboratories, Inc. and changed its name to AVAX Technologies, Inc. in March 1996. AVAX Technologies, Inc. was founded in 1990 and is based in Philadelphia, Pennsylvania.

Industry, Sector and Symbol

Stock Exchange OTCMKTSMKTS
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTSMKTS:AVXT
CUSIPN/A
CIKN/A
Phone215-241-9760
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive AVXT News and Ratings via Email

Sign-up to receive the latest news and ratings for AVXT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AVAX Technologies (OTCMKTSMKTS:AVXT) Frequently Asked Questions

What stocks does MarketBeat like better than AVAX Technologies?

Wall Street analysts have given AVAX Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AVAX Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of AVAX Technologies' key competitors?

What other stocks do shareholders of AVAX Technologies own?

What is AVAX Technologies' stock symbol?

AVAX Technologies trades on the OTCMKTSMKTS under the ticker symbol "AVXT."

How do I buy shares of AVAX Technologies?

Shares of AVXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does AVAX Technologies have?

AVAX Technologies employs 9 workers across the globe.

What is AVAX Technologies' official website?

The official website for AVAX Technologies is www.avax-tech.com.

How can I contact AVAX Technologies?

The company can be reached via phone at 215-241-9760.


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.